Distortion of allelic expression of apolipoprotein E in Alzheimer's disease

被引:85
作者
Lambert, JC
PerezTur, J
Dupire, MJ
Galasko, D
Mann, D
Amouyel, P
Hardy, J
Delacourte, A
ChartierHarlin, MC
机构
[1] INST PASTEUR,INSERM,CJF9505,F-59019 LILLE,FRANCE
[2] INSERM,U422,F-59045 LILLE,FRANCE
[3] MAYO CLIN JACKSONVILLE,JACKSONVILLE,FL 32224
[4] UNIV CALIF SAN DIEGO,MED CTR,PULMAN AMBULATORY CARE CTR,LA JOLLA,CA 92037
[5] UNIV MANCHESTER,DEPT PATHOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND
关键词
D O I
10.1093/hmg/6.12.2151
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The APOE epsilon 4 allele is a strong genetic susceptibility factor for Alzheimer's disease. Interaction with other biological factors may modulate the effect of the apoE isoforms. However, previous work suggested that other genetic variability within the APOE locus, influencing the effect of the epsilon 4 allele, may exist. Such variability could modify the expression of the APOE gene and, in particular, the level of expression of APOE alleles could be an important determinant of disease pathogenesis. To test this hypothesis we examined the levels of expression of APOE in heterozygotes with AD and in controls, using a new method of semi-quantitation. We report that relative epsilon 4 mRNA expression is increased in AD compared with controls and suggest that genetic variability in the neural expression of APOE contributes to disease risk.
引用
收藏
页码:2151 / 2154
页数:4
相关论文
共 24 条
[1]   ASSOCIATION OF APOLIPOPROTEIN-E GENOTYPE WITH BRAIN LEVELS OF APOLIPOPROTEIN-E AND APOLIPOPROTEIN J(CLUSTERIN) IN ALZHEIMER-DISEASE [J].
BERTRAND, P ;
POIRIER, J ;
ODA, T ;
FINCH, CE ;
PASINETTI, GM .
MOLECULAR BRAIN RESEARCH, 1995, 33 (01) :174-178
[2]   APOLIPOPROTEIN-E, EPSILON-4 ALLELE AS A MAJOR RISK FACTOR FOR SPORADIC EARLY AND LATE-ONSET FORMS OF ALZHEIMERS-DISEASE - ANALYSIS OF THE 19Q13.2 CHROMOSOMAL REGION [J].
CHARTIERHARLIN, MC ;
PARFITT, M ;
LEGRAIN, S ;
PEREZTUR, J ;
BROUSSEAU, T ;
EVANS, A ;
BERR, C ;
VIDAL, O ;
ROQUES, P ;
GOURLET, V ;
FRUCHART, JC ;
DELACOURTE, A ;
ROSSOR, M ;
AMOUYEL, P .
HUMAN MOLECULAR GENETICS, 1994, 3 (04) :569-574
[3]   NEUROPATHOLOGICAL CHANGES IN SCRAPIE AND ALZHEIMERS-DISEASE ARE ASSOCIATED WITH INCREASED EXPRESSION OF APOLIPOPROTEIN-E AND CATHEPSIN-D IN ASTROCYTES [J].
DIEDRICH, JF ;
MINNIGAN, H ;
CARP, RI ;
WHITAKER, JN ;
RACE, R ;
FREY, W ;
HAASE, AT .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4759-4768
[4]   APOLIPOPROTEIN-E IS A KINETIC BUT NOT A THERMODYNAMIC INHIBITOR OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS AND TREATMENT OF ALZHEIMER-DISEASE [J].
EVANS, KC ;
BERGER, EP ;
CHO, CG ;
WEISGRABER, KH ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (03) :763-767
[5]  
GILMOUR RS, 1972, J BIOL CHEM, V247, P4621
[6]  
GUILLAUME D, 1995, RES ADV ALZHEIMERS D, P386
[7]  
Harr SD, 1996, J NEUROCHEM, V66, P2429
[8]  
HIXON JE, 1990, J LIPID RES, V31, P545
[9]   Accumulation of apolipoprotein E and beta-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death [J].
Ishimaru, H ;
Ishikawa, K ;
Haga, S ;
Shoji, M ;
Ohe, Y ;
Haga, C ;
Sasaki, A ;
Takashashi, A ;
Maruyama, Y .
NEUROREPORT, 1996, 7 (18) :3063-3067
[10]  
LAMBERT JC, 1997, UNPUB NUCL ACIDS RES